Berge A Minassian (Berge A Minassian)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Traumatic Brain Injury

Dna Methylation

Top Venues

Disease models & mechanisms

EMBO molecular medicine

Annals of clinical and translational neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO molecular medicine 16 (5) (2024)
Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO molecular medicine (2024)
Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO molecular medicine 16 (5) (2024)
Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO molecular medicine 16 (5) (2024)
Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
Amylopectinosis of the fatal epilepsy Lafora disease resists autophagic glycogen catabolism. EMBO molecular medicine 16 (5) (2024)
Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha, Ummay Marriam, Sharyl Fyffe-Maricich, Amy Lin, Xin Chen, Steven J Gray, Berge A Minassian
CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy. Gene therapy 31 (5-6) (2023)
Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha, Ummay Marriam, Sharyl Fyffe-Maricich, Amy Lin, Xin Chen, Steven J Gray, Berge A Minassian
CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy. Gene therapy (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha, Ummay Marriam, Sharyl Fyffe-Maricich, Amy Lin, Xin Chen, Steven J Gray, Berge A Minassian
CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy. Gene therapy 31 (5-6) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy. Disease models & mechanisms 16 (1) (2023)
Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha, Ummay Marriam, Sharyl Fyffe-Maricich, Amy Lin, Xin Chen, Steven J Gray, Berge A Minassian
CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy. Gene therapy 31 (5-6) (2023)
Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin Chown, Mathew Dear, Dikran R Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A Minassian
Lafora progressive myoclonus-epilepsy: Laforin targets malin to glycogen. Disease models & mechanisms (2022)
Claudia Moreau, Frédérique Tremblay, Stefan Wolking, Alexandre Girard, Catherine Laprise, Fadi F Hamdan, Jacques L Michaud, Berge A Minassian, Patrick Cossette, Simon L Girard
Assessment of burden and segregation profiles of CNVs in patients with epilepsy. Annals of clinical and translational neurology 9 (7) (2022)
Reem A Alkhater, Saija Ahonen, Berge A Minassian
SUCLA2 Arg407Trp mutation can cause a nonprogressive movement disorder - deafness syndrome. Annals of clinical and translational neurology 8 (1) (2020)
Lori Israelian, Silvia Nitschke, Peixiang Wang, Xiaochu Zhao, Ami M Perri, Jennifer P Y Lee, Brandy Verhalen, Felix Nitschke, Berge A Minassian
Ppp1r3d deficiency preferentially inhibits neuronal and cardiac Lafora body formation in a mouse model of the fatal epilepsy Lafora disease. Journal of neurochemistry 157 (6) (2020)
Seiji N Sugiman-Marangos, Greg L Beilhartz, Xiaochu Zhao, Dongxia Zhou, Rong Hua, Peter Kijun Kim, James M Rini, Berge A Minassian, Roman A Melnyk
Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy. Science advances 6 (50) (2020)
Erin E Chown, Peixiang Wang, Xiaochu Zhao, Justin J Crowder, Jordan W Strober, Mitchell A Sullivan, Yunlin Xue, Cody S Bennett, Ami M Perri, Bret M Evers, Peter J Roach, Anna A Depaoli-Roach, H Orhan Akman, Bartholomew A Pederson, Berge A Minassian
GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease. Annals of clinical and translational neurology 7 (11) (2020)
Felix Nitschke, Mitchell A Sullivan, Peixiang Wang, Xiaochu Zhao, Erin E Chown, Ami M Perri, Lori Israelian, Lucia Juana-López, Paola Bovolenta, Santiago Rodríguez de Córdoba, Martin Steup, Berge A Minassian
Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. EMBO molecular medicine 9 (7) (2018)